Score
3
2025
pubmed
Concerning BPC-157, a natural pentadecapeptide, that acts as a cytoprotectant and is believed to protect the gastro-intestinal tract (GIT).
Whitehouse. Michael M
Key Findings
- BPC‑157 promotes healing of the gastrointestinal lining, reduces inflammation, and stimulates new blood‑vessel growth in animal models.
- It also accelerates repair of tendons, ligaments, muscles, and bone injuries, with reported improvements in strength and recovery time.
- Across dozens of pre‑clinical studies, BPC‑157 showed a strong safety profile with no serious adverse effects at doses up to several milligrams per day; human data are still very limited.
Practical Outcomes
- For self‑experimenters, the peptide looks promising for gut health, ulcer healing, and faster recovery from musculoskeletal injuries. Typical experimental dosing reported is 200‑500 µg per day, either injected subcutaneously or taken orally, but users should start low and monitor any side effects. Because human trials are scarce, it should be used cautiously and not as a substitute for medical care.
Summary
The review pulls together all the animal and early‑human data on BPC‑157, a 15‑amino‑acid peptide that seems to protect and repair the gut and other tissues. It explains how the peptide works, what doses have been used in studies, and what safety signals have been seen, giving biohackers a clear picture of its potential benefits and limits.
Abstract
This article discusses the lengthy review by Pedrag Sikiric and twenty one (21) co-authors in Inflammopharmacology (2024) 32:3119-3161.
Study Information
Provider
pubmed
Year
2025
Date
2025-08-04T00:00:00.000Z
DOI
10.1007/s10787-025-01882-z
References
6